Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-04

Clinical Trial Update: Ticagrelor Therapy for RefrACTORy Migraine Study [Phase 4]

View source ↗

Summary

Phase 4 trial update on ticagrelor therapy for refractory migraine completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

Sponsor: Columbia University | Conditions: Migraine, Headache | Phase 4 | Status: COMPLETED | Results posted: 2019-06-04